Related Experiment Video

Updated: Dec 29, 2025

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.6K

Commentary: Arginine vasopressin receptor 1a is a therapeutic target for castration-resistant prostate cancer

Giselle V Ripoll1,2, Marina Pifano1, Juan Garona1,2

  • 1Laboratory of Molecular Oncology, Department of Science and Technology, National University of Quilmes, Bernal, Argentina.

Frontiers in Oncology
|January 31, 2020
PubMed
Abstract

No abstract available in PubMed .

Keywords:
desmopressindrug repurposinghormone-resistant cancerrelcovaptanvasopressin

More Related Videos

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients12:13

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Published on: November 19, 2019

7.1K
Continuous IV Infusion is the Choice Treatment Route for Arginine-vasopressin Receptor Blocker Conivaptan in Mice to Study Stroke-evoked Brain Edema08:44

Continuous IV Infusion is the Choice Treatment Route for Arginine-vasopressin Receptor Blocker Conivaptan in Mice to Study Stroke-evoked Brain Edema

Published on: September 1, 2016

9.2K

Related Concept Videos